Similar Papers

Paper Title
Journal
Date
Author
Validation of Residual Proliferative Cancer Burden as a Predictor of Long-Term Outcome Following Neoadjuvant Chemotherapy in Patients with Hormone Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer.
Federica Miglietta ... Grazia Vernaci
The Oncologist | VOL. 25
Federica Miglietta, et. al.Federica Miglietta ... Grazia Vernaci
21 Jul 2020
Abstract P5-06-12: Validation of residual proliferative cancer burden (RPCB) as a predictor of long-term outcome following neoadjuvant chemotherapy in hormone-receptor positive/HER2 negative breast cancer patients
Federica Miglietta ... Grazia Vernaci
Cancer Research | VOL. 80
Federica Miglietta, et. al.Federica Miglietta ... Grazia Vernaci
14 Feb 2020
Abstract P4-02-07: Early Optical Tomography Changes Predict Breast Cancer Response to Neoadjuvant Chemotherapy
Ea Lim ... S Feldman
Cancer Research | VOL. 72
Ea Lim, et. al.Ea Lim ... S Feldman
15 Dec 2012
Integration of Ki67 with residual cancer burden (RCB) compared to Ki67 or RCB alone to predict long-term term outcome following neoadjuvant chemotherapy.
Amna Sheri ... Simone Detre
Journal of Clinical Oncology | VOL. 31
Amna Sheri, et. al.Amna Sheri ... Simone Detre
20 May 2013
View more papers

More From: Cancer Research

Paper Title
Journal
Date
Author
Accumulation of CD38 in Hybrid Epithelial/Mesenchymal Cells Promotes Immune Remodeling and Metastasis in Breast Cancer.
Tanvi H Visal ... Sendurai A Mani
Cancer research | VOL. -
Tanvi H Visal, et. al.Tanvi H Visal ... Sendurai A Mani
24 Jan 2025
Mutant KRAS and CK2 Cooperatively Stimulate SLC16A3 Activity to Drive Intrahepatic Cholangiocarcinoma Progression.
Ran Chen ... Daming Gao
Cancer research | VOL. -
Ran Chen, et. al.Ran Chen ... Daming Gao
24 Jan 2025
Targeting TUT1 Depletes Tri-snRNP Pools to Suppress Splicing and Inhibit Pancreatic Cancer Cell Survival.
Ziwei Guo ... Mo Chen
Cancer research | VOL. -
Ziwei Guo, et. al.Ziwei Guo ... Mo Chen
24 Jan 2025
Comparison of Lean, Obese, and Weight Loss Models Reveals TREM2 Deficiency Attenuates Breast Cancer Growth Uniquely in Lean Mice and Alters Clonal T Cell Populations.
Elysa W Pierro ... Alyssa H Hasty
Cancer research | VOL. -
Elysa W Pierro, et. al.Elysa W Pierro ... Alyssa H Hasty
22 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.